Syncom Formul.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE312C01025
  • NSEID: SYNCOMF
  • BSEID: 524470
INR
23.36
-0.22 (-0.93%)
BSENSE

Oct 09

BSE+NSE Vol: 1.43 cr

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Fredun Pharma
Shukra Pharma.
Venus Remedies
Sakar Healthcare
Syncom Formul.
Beta Drugs Ltd
Hikal
Indoco Remedies
Advanced Enzyme
Dishman Carbogen
Sai Parenteral's
Why is Syncom Formulations (India) Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of -63.92% and Operating profit at -50.69% over the last 5 years
2
Stock is technically in a Mildly Bearish range
  • The stocks MACD and KST technical factors are also Bearish
3
With ROE of 16.6, it has a Fair valuation with a 3.6 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -18.63%, its profits have risen by 76.1% ; the PEG ratio of the company is 0.3
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
5
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 0.10% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -18.63% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Syncom Formul. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Syncom Formul. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Syncom Formul.
37.82%
-0.50
37.46%
Sensex
-11.64%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-53.39%
EBIT Growth (5y)
-42.14%
EBIT to Interest (avg)
30.08
Debt to EBITDA (avg)
0.72
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
9.88
Tax Ratio
24.37%
Dividend Payout Ratio
12.30%
Pledged Shares
0
Institutional Holding
0.35%
ROCE (avg)
80.28%
ROE (avg)
119.22%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
26
Industry P/E
36
Price to Book Value
5.34
EV to EBIT
25.96
EV to EBITDA
23.97
EV to Capital Employed
6.93
EV to Sales
4.23
PEG Ratio
0.53
Dividend Yield
0.42%
ROCE (Latest)
23.35%
ROE (Latest)
18.41%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
PAT(Latest six months)

At Rs 50.02 cr has Grown at 49.75%

ROCE(HY)

Highest at 24.55%

PBDIT(Q)

Highest at Rs 26.21 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 20.88%

PBT LESS OI(Q)

Highest at Rs 24.42 cr.

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Syncom Formul.
Profit After Tax (PAT) - Latest six months
At Rs 50.02 cr has Grown at 49.75%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 26.21 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 24.42 cr has Grown at 40.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 17.44 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 20.88%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 24.42 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)